2nd Circ. Boots Medtronic Infuse Suit For Overstepping FDA
The Second Circuit on Tuesday refused to revive a spinal patient's lawsuit accusing Medtronic Inc. of fraud and negligence after her Infuse bone graft device led to excess bone growth, finding...To view the full article, register now.
Already a subscriber? Click here to view full article